Navigation Links
Sequenom Announces Participation at William Blair and Company 5th Annual Emerging Growth Stock Conference

SAN DIEGO, Sept. 1, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the William Blair and Company 5th Annual Emerging Growth Stock Conference at the Intercontinental New York Barclay Hotel in New York City on September 8, 2011.

Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will present on Thursday, September 8, 2011 beginning at 2:00 p.m. ET, to provide an overview of and update on the Company.  The presentation is expected to last approximately 40 minutes and will be web cast live through the "Investors" section of the Sequenom website at  An audio replay will be available for 30 days following the initial presentation web cast.  

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

SEQUENOM ® is a trademark of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.


SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequenom Announces Multi-Year Supply Agreement With Illumina
2. Technology Collaboration Between New England Biolabs and Sequenom Delivers First Product for Epigenetics
3. Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
4. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test
6. Sequenom to Present at Two Financial Conferences in November
7. Sequenom Announces Date of Second Quarter 2010 Financial Results and Conference Call
8. Sequenom to Present at the Jefferies 2010 Global Life Sciences Conference
9. Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit
10. Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results
11. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
Post Your Comments:
(Date:11/30/2015)... 2015 North America was ... grow at a CAGR of 7.6% from 2015 to 2020. ... 135.6 million in 2014, and is expected to grow at a ... to the new Market Research Report "North America Cardiac Output Monitoring ... (Hospitals, ambulatory care, others) - Analysis And Forecast To 2020", the ...
(Date:11/30/2015)... --> --> ... by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application ... Geography - Global Forecast to 2020", published by MarketsandMarkets, is ... CAGR of 5.2% during the forecast period from 2015 to ... 62 Figures spread through 167 P ages and in-depth ...
(Date:11/30/2015)... MOUNTLAKE TERRACE, Wash. and ST. ... Cross and Express Scripts (NASDAQ: ESRX ) today ... benefit agreement. The partnership, which began in 1999, will ... --> --> After evaluating pharmacy ... process, Premera concluded that Express Scripts continues to offer ...
Breaking Medicine Technology:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Foundation (Meso Foundation) released information for caregivers and held two webinars on topics ... available on demand free of charge at . , With a ...
(Date:11/30/2015)... ... November 30, 2015 , ... Thermi™, a world ... announce that its ThermiRFR temperature controlled radiofrequency platform has received CE marking and ... platform which uses temperature as a clinical endpoint. The technology has been ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... vehicle experience this summer, ushering in a new era of publicly accessible automated ... electric shuttle, will continue to offer guests an up-close look at the shuttle ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, 2015, at the Mill ... fundraising event, a 5K walk known as “Making Strides Against Breast Cancer”. Patients and ... is also located in Battle Creek, joined in for this campaign that sought to ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the week of ... raise funds for its research, education, support, and advocacy efforts. The campaign is ... , The Mesothelioma Applied Research Foundation, which also goes by Meso Foundation, holds ...
Breaking Medicine News(10 mins):